KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Abbott Laboratories (ABT) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $0.94.

  • Abbott Laboratories' EPS (Weighted Average and Diluted) changed 0.0% to $0.94 in Q3 2025 from the same period last year, while for Sep 2025 it was $7.97, marking a year-over-year increase of 14224.92%. This contributed to the annual value of $7.67 for FY2024, which is 13518.55% up from last year.
  • Latest data reveals that Abbott Laboratories reported EPS (Weighted Average and Diluted) of $0.94 as of Q3 2025, which was down 0.0% from $1.01 recorded in Q2 2025.
  • In the past 5 years, Abbott Laboratories' EPS (Weighted Average and Diluted) ranged from a high of $5.28 in Q4 2024 and a low of $0.59 during Q4 2022
  • Its 5-year average for EPS (Weighted Average and Diluted) is $1.13, with a median of $0.91 in 2023.
  • As far as peak fluctuations go, Abbott Laboratories' EPS (Weighted Average and Diluted) crashed by 4684.68% in 2022, and later soared by 48019.21% in 2024.
  • Abbott Laboratories' EPS (Weighted Average and Diluted) (Quarter) stood at $1.11 in 2021, then crashed by 46.85% to $0.59 in 2022, then skyrocketed by 54.24% to $0.91 in 2023, then surged by 480.19% to $5.28 in 2024, then tumbled by 82.2% to $0.94 in 2025.
  • Its EPS (Weighted Average and Diluted) stands at $0.94 for Q3 2025, versus $1.01 for Q2 2025 and $0.76 for Q1 2025.